Onkologische Rehabilitation:Evaluation der Effektivität stationärer onkologischer Rehabilitationsmaßnahmen

Autor: Teichmann Jv

Publikováno v: Die Rehabilitation. 41:53-63

Background There are only few studies on the evaluation of the efficiency of oncologic rehabilitation. The objective of this study was to determine the efficiency of a complex rehabilitation programme consisting of medical care, physical therapy, spo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e936656484ba3825bfa53bda8fdacccd
https://doi.org/10.1055/s-2002-19952

Ambiguous phenotypes and genotypes in 16 children with acute leukemia as characterized by multiparameter analysis

Autor: Ludwig, WD, Bartram, CR, Ritter, J, Raghavachar, A, Hiddemann, W, Heil, G, Harbott, J, Seibt-Jung, H, Teichmann, JV, Riehm, H

Publikováno v: Blood; June 1988, Vol. 71 Issue: 6 p1518-1528, 11p

Incidence and prognostic significance of immunophenotypic subgroups in childhood acute lymphoblastic leukemia: experience of the BFM study 86.

Autor: Ludwig WD; Department of Hematology and Oncology, Klinikum Steglitz, Free University of Berlin, Fed. Rep. of Germany., Harbott J, Bartram CR, Komischke B, Sperling C, Teichmann JV, Seibt-Jung H, Notter M, Odenwald E, Nehmer A, et. al.

Publikováno v: Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer [Recent Results Cancer Res] 1993; Vol. 131, pp. 269-82.

Susceptibility of human leukemia to allogeneic and autologous lymphokine-activated killer cell activity: analysis of 252 samples.

Autor: Teichmann JV; Department of Hematology and Oncology, Universitätsklinikum Steglitz, Free University of Berlin, FRG., Ludwig WD, Thiel E

Publikováno v: Natural immunity [Nat Immun] 1992 May-Jun; Vol. 11 (3), pp. 117-32.

Augmentation of the Susceptibility of Human Leukemia to Lymphokine-Activated Killer (LAK) Cells by Exposure of the Leukemic Target Cells to Cytotoxic Drugs in Vitro and in Vivo.

Autor: Teichmann JV; a Department of Hematology and Oncology, Universitaetsklinikum Steglitz, Free University of Berlin, Berlin, Germany., Ludwig WD; a Department of Hematology and Oncology, Universitaetsklinikum Steglitz, Free University of Berlin, Berlin, Germany., Thiel E; a Department of Hematology and Oncology, Universitaetsklinikum Steglitz, Free University of Berlin, Berlin, Germany.

Publikováno v: Leukemia & lymphoma [Leuk Lymphoma] 1991; Vol. 5 (4), pp. 263-71.